Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Keith L Mcintosh Insider Profile
4 Followers
Keith L Mcintosh, Director at CareRx, holds 34.70K shares in CareRx (Ticker: TSE:CRRX). Most recently, Keith L Mcintosh Bought C$20,500 shares of CareRx on Sep 11, 2024 for an estimated value of 39.98K.
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+31.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Keith L Mcintosh's holdings
Insider Roles
Director
Roles that Keith L Mcintosh holds in companies
Most Profitable Insider Trade
The most profitable trade made by Keith L Mcintosh
Keith L Mcintosh's Trading History
List of latest transactions for each holding click on a transaction to see Keith L Mcintosh's performance on stock
You May Also Like
Keith L Mcintosh insider profile FAQ
What is the percentage of profitable transactions made by Keith L Mcintosh?
The percentage of profitable transactions made by Keith L Mcintosh is 100%.
What is the average return per transaction made by Keith L Mcintosh?
The average return per transaction made by Keith L Mcintosh is 31.70%.
What stocks does Keith L Mcintosh hold?
Keith L Mcintosh holds: TSE:CRRX stocks.
What was Keith L Mcintosh’s latest transaction?
Keith L Mcintosh latest transaction was an Informative Buy of C$39.98K.
What was Keith L Mcintosh's most profitable transaction?
Keith L Mcintosh’s most profitable transaction was an Informative Sell of TSE:CRRX stock on October 27, 2022. The return on the trade was 49.50%.
What is Keith L Mcintosh's role in CareRx?
Keith L Mcintosh's role in CareRx is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.